# EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

> **NCT02561897** · PHASE4 · TERMINATED · sponsor: **Electrophysiology Research Foundation** · enrollment: 5 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Edoxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT02561897
- **Lead sponsor:** Electrophysiology Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2017-09
- **Final completion:** 2017-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Did not meet enrolment target for phase 1
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561897, "EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02561897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*